Way 316606 is the drug for the treatment of hair loss dwindled, perhaps due more to commercial potential and chemical stability reasons than efficacy as the later studies of Setipiprant have focused on different chemical forms of the drug and combining it with various nanoparticles to enhance delivery.

WAY-316606 is a drug used in the treatment of osteoporosis - a condition that causes fragile bones and increases susceptibility to fractures. It's a SFRP1 inhibitor, which means it prevents the protein SFRP1 from being produced and activated.

Function

1. Increase cellular proliferation of outer root sheeth cells.
2. Increase hair diameter and hair density.
3. Increase the percentage of hair in the anagen phase.
4. Exert no negative effect on body hormone levels.
5. Provide equivalent or better net growth than Finasteride.